KW2871 Uses, Dosage, Side Effects and more

KW2871 has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.

Trade Name KW2871
Generic Ecromeximab
Ecromeximab Other Names Ecromeximab, KW2871
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share